PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Feb 2021)
What this means for you
This application is over — abandoned 15 Feb 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87503353
- Mark type
- Design + words
- Filed
- 23 Jun 2017
- Published for opposition
- 14 Nov 2017
- Abandoned
- 15 Feb 2021
- Attorney of record
- Harold Milstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, diabetes, and central nervous system, autoimmune, bone, metabolic, and blood disorders
Owner
- Plexxikon Inc., Berkeley, CA, US
- Plexxikon Inc., Berkeley, CA, US
Prosecution history
- 16 Feb 2021 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 15 Feb 2021 — ABANDONMENT - NO USE STATEMENT FILED
- 21 Jul 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Jul 2020 — SOU EXTENSION 5 GRANTED
- 08 Jul 2020 — SOU EXTENSION 5 FILED
- 08 Jul 2020 — SOU TEAS EXTENSION RECEIVED
- 04 Feb 2020 — CORRECTED NOA E-MAILED
- 03 Feb 2020 — DIVISIONAL PROCESSING COMPLETE
- 06 Jan 2020 — DIVISIONAL REQUEST RECEIVED
- 03 Feb 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Jan 2020 — TEAS REQUEST TO DIVIDE RECEIVED
- 04 Jan 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jan 2020 — SOU EXTENSION 4 GRANTED
- 02 Jan 2020 — SOU EXTENSION 4 FILED
- 02 Jan 2020 — SOU TEAS EXTENSION RECEIVED